Interestingly, comparing triplets to Doublet_ARPI only showed a trend towards improved OS (HR: 0.80; 95% CI: 0.63-1.03), but this difference was not statistically significant.
← all excerpts
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis.
1
—
—